Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that targeting 5α-reductase, the androgen receptor, and hair growth genes, along with using compounds with anti-androgenic properties, could lead to more effective hair loss treatments.

Androgens like testosterone are important hormones for both men and women, made differently in each sex and affecting the body by regulating genes and quick interactions with cell components.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

A mix of sulforaphane, L-menthol, and dexpanthenol could help increase hair growth and reduce hair loss.

Hair loss in men is mainly caused by hormones and genes, and while current treatments can slow it down, they can't fully stop it.

Blocking glucocorticoid receptors improves glucose metabolism in a PCOS mouse model.

Women with AGA have more androstenedione and dihydrotestosterone, less copper and zinc; copper imbalance affects AGA; treatment improves hormones and minerals.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

5α-reductase is essential for male sexual development and its inhibitors have potential in treating various conditions related to hormone action.

New treatments for male hypogonadism are effective and should be personalized.

Dihydrotestosterone increases the activity of an enzyme in pubic skin cells that converts testosterone to dihydrotestosterone.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Dihydrotestosterone increases certain inflammatory signals in skin cells, potentially contributing to acne.

TR3 is mainly found in hair follicle stem cells and may be involved in hair loss.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

Clascoterone may be a promising treatment for hair loss.

AR gene variations don't affect aging markers in men.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Inhibiting 5α-reductase can help reduce prostate cancer risk and improve treatment.

DHT stops hair regrowth in mice, similar to human hair loss.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Male sexual differentiation is regulated independently, while female differentiation occurs in an androgenic environment, affecting conditions like congenital adrenal hyperplasia.

DHT, a testosterone byproduct, causes male pattern baldness.

Purple corn extract may help reduce prostate enlargement and inflammation.

5α‐reductase isozymes are crucial for prostate development and health, and targeting them can help prevent and treat prostate issues.

Men with common hair loss may have a higher risk of heart disease and diabetes, and should be checked for these conditions.